# Intravenous Injection of Adipose Derived Mesenchymal Stem Cell for ALS

> **NCT02492516** · PHASE1 · COMPLETED · sponsor: **Royan Institute** · enrollment: 19 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **BIOLOGICAL:** mesenchymal stem cells

## Key facts

- **NCT ID:** NCT02492516
- **Lead sponsor:** Royan Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2017-03
- **Final completion:** 2017-04
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2017-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02492516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02492516, "Intravenous Injection of Adipose Derived Mesenchymal Stem Cell for ALS". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02492516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*